/Companies

Xylyx Bio

New York, US · 1 known investors

Find your way into Xylyx Bio

Each arrow is one introduction. Sign up to fill in the first one.

1,260 people can intro you to John

Ask Simon Lapointe to introduce you to John O'Neill

You →Simon · together at CDL-Vancouver Biomedical Engineering 2025/26 →John

Sign up to find every way you can get introduced to Xylyx Bio

  • Your email: who you already know at Xylyx Bio, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Xylyx Bio team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

XYLYX develops transplantation technologies using regenerative medicine, bioengineering, and translational science to expand access to organ transplantation. The company works with surgeons, physicians, and regenerative medicine experts to advance tissue engineering and clinical innovation for transplant applications.

Founders & leadership

JOJohn O'Neill
John O'NeillChief Scientific Officer, Co-Founder, Board DirectorJohn O'Neill is Chief Scientific Officer and Co-Founder of Xylyx Bio, which develops regenerative medicine and bioengineering technologies for organ transplantation. His background spans translational science, tissue engineering, and work with surgical and regenerative medicine experts on transplant applications.

Investors · 1

Non-dilutive funding · 4 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2022$2.1M
National Institutes of Health (NIH)National Institutes of HealthPhase I2021$297.9K
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$224.1K
National Institutes of Health (NIH)National Institutes of HealthPhase I2018$279.4K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

Frequently asked questions

What does Xylyx Bio do?
XYLYX develops transplantation technologies using regenerative medicine, bioengineering, and translational science to expand access to organ transplantation. The company works with surgeons, physicians, and regenerative medicine experts to advance tissue engineering and clinical innovation for transplant applications.
Who founded Xylyx Bio?
Xylyx Bio was founded by John O'Neill.
Who are Xylyx Bio's investors?
Xylyx Bio's investors include Boston Harbor Angels.
Where is Xylyx Bio headquartered?
Xylyx Bio is headquartered in New York, US.